Bangladesh’s stock market is set for a major reshuffle in a key international equity benchmark, with six companies entering the MSCI Bangladesh Standard Index and four leaving it as the index provider resumes regular reviews after more than three years of exceptional treatment linked to local stock price restrictions.
Announced on 11 November as part of MSCI’s November 2026 Frontier Markets Index Review, the changes will take effect at the close of trading on November 30, with the revised constituents becoming effective from December 1.
MSCI suspended routine changes for Bangladesh in February 2023, citing investor concerns over market accessibility.
The resumption could affect how foreign funds tracking the benchmark allocate investments across Bangladeshi shares, although the impact on individual stocks will depend on their revised index weights and fund holdings.
The six additions to the Standard Index are Beximco Pharmaceuticals, BRAC Bank, City Bank, Eastern Bank, LafargeHolcim Bangladesh and Prime Bank. Bangladesh Export Import Company, Renata, Robi Axiata and United Power are being removed.
“The entry of four banks represents a notable shift in the benchmark’s composition, which was previously dominated by pharmaceuticals and other non-financial companies,” said IDLC Securities Head of International and Institutional Sales Suman Saha.
Square Pharmaceuticals, Grameenphone and BAT Bangladesh will retain their places in the Standard Index.
The reshuffle increases the number of Bangladeshi stocks in the MSCI Frontier Markets Standard Index to nine from seven. Bangladesh accounts for six of the 12 global additions and four of the 10 deletions in this review.
The companies’ respective weights could also change as the additions and deletions alter the benchmark’s overall market capitalisation base.
BRAC Bank among largest global additions
BRAC Bank’s inclusion is particularly significant in the latest global reshuffle.
Based on full company market capitalisation, it ranks as the second-largest addition to the MSCI Frontier Markets Index worldwide, behind Oman’s Oman Arab Bank and ahead of Kenya’s NCBA Group.
The ranking places a Bangladeshi bank among the most prominent companies entering the frontier-market benchmark in this review.
The changes also extend to the MSCI Bangladesh Small Cap Index, which will see 83 additions and eight deletions, substantially expanding the number of Bangladeshi companies represented.
Five companies – Beximco Pharmaceuticals, BRAC Bank, City Bank, LafargeHolcim Bangladesh and Prime Bank – are moving from the Small Cap Index to the Standard Index.
Eastern Bank is the sixth Standard Index addition but is not among the eight companies removed from the Small Cap Index.
Bangladesh Export Import Company is moving in the opposite direction, leaving the Standard Index and joining the Small Cap Index.
The other three companies removed from the Small Cap Index are Dutch-Bangla Bank, Export Import Bank of Bangladesh and Power Grid of Bangladesh. None is among the announced additions to the Standard Index.
The end of exceptional treatment
The resumption of regular reviews follows a series of developments involving trading restrictions in Bangladesh’s stock market.
MSCI resumed index reviews in August 2021, when BAT Bangladesh and Robi Axiata were among the companies added. However, the reintroduction of market-wide floor prices in July 2022 restricted trading, affecting liquidity and price discovery.
In February 2023, MSCI suspended regular index changes for Bangladesh amid investor concerns over market accessibility.
The restrictions were gradually removed, with all remaining affected securities released from floor-price restrictions on June 9, 2026.
Foreign fund flows still remain uncertain
The additions could increase benchmark-related demand for the six newly included companies, while the four deletions could reduce benchmark-linked holdings in those stocks, according to an IDLC Securities research report.
However, inclusion does not automatically translate into higher share prices or a specific amount of foreign investment.
Actual fund flows will depend on individual companies’ revised index weights, the assets managed by funds tracking the benchmark, existing holdings and available trading liquidity.
Even companies retaining their places could see changes in their benchmark weights. Square Pharmaceuticals, Grameenphone and BAT Bangladesh, for instance, may have their weights adjusted as the total index capitalisation changes following the reshuffle and revisions to foreign inclusion factors.
Investors may begin assessing the potential impact following the 11 November announcement.
Funds tracking the index could adjust their portfolios around the November 30 implementation, potentially increasing trading activity and short-term volatility.
The restoration of regular index maintenance could improve the visibility of Bangladeshi companies among international institutional investors and expand the country’s representation in the frontier-market benchmark.
However, foreign exchange availability, repatriation and trade execution constraints remain relevant considerations for overseas investors.
“The reshuffle is a step towards normalising Bangladesh’s position in the international index system, but its longer-term effects on market liquidity and foreign investment will depend on conditions beyond index inclusion,” IDLC Securities said.
